<DOC>
	<DOCNO>NCT00668564</DOCNO>
	<brief_summary>The primary objective clinical trial evaluate ability achieve sustain donor engraftment patient lysosomal peroxisomal inborn error metabolism undergoing hematopoietic stem cell transplantation ( HCT ) .</brief_summary>
	<brief_title>Hematopoietic Stem Cell Transplantation ( HCT ) Inborn Errors Metabolism</brief_title>
	<detailed_description>This ongoing area interest group Univ . Minnesota , new protocol take place several old protocol . While survival good prior protocol past decade , incomplete engraftment remain somewhat problematic . Therefore , modify preparative regimen somewhat increase engraftment replace anti-thymocyte globulin ( ATG ) Campath-1H , drug immune suppressive . In addition , modify supportive care regimen . Based , monitor level anti-oxidant therapy ( N-acetylcysteine ) biomarkers inflammation oxidative stress family consent research study .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolism , Inborn Errors</mesh_term>
	<mesh_term>Pick Disease Brain</mesh_term>
	<mesh_term>Aphasia , Primary Progressive</mesh_term>
	<mesh_term>Frontotemporal Dementia</mesh_term>
	<mesh_term>Mucopolysaccharidosis I</mesh_term>
	<mesh_term>Mannosidase Deficiency Diseases</mesh_term>
	<mesh_term>alpha-Mannosidosis</mesh_term>
	<mesh_term>Wolman Disease</mesh_term>
	<mesh_term>Niemann-Pick Diseases</mesh_term>
	<mesh_term>Niemann-Pick Disease , Type A</mesh_term>
	<mesh_term>Niemann-Pick Disease , Type C</mesh_term>
	<mesh_term>Leukodystrophy , Globoid Cell</mesh_term>
	<mesh_term>Sphingolipidoses</mesh_term>
	<mesh_term>Mucopolysaccharidosis VI</mesh_term>
	<mesh_term>Mucopolysaccharidosis VII</mesh_term>
	<mesh_term>Fucosidosis</mesh_term>
	<mesh_term>Aspartylglucosaminuria</mesh_term>
	<mesh_term>Niemann-Pick Disease , Type B</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<mesh_term>Alemtuzumab</mesh_term>
	<criteria>Mucopolysaccharidosis ( MPS ) Disorders : MPS IH ( Hurler syndrome ) MPSVI ( MaroteauxLamy syndrome ) MPS VII ( Sly syndrome ) . Glycoprotein metabolic disorder : Alpha mannosidosis Fucosidosis Aspartylglucosaminuria Sphingolipidoses Recessive Leukodystrophies : Presymptomatic patient globoid cell leukodystrophy ( GLD , also know Krabbe disease ) metachromatic leukodystrophy ( MLD ) eligible treatment protocol . White matter disease magnetic resonance imaging ( MRI ) alone exclusion patient asymptomatic . Peroxisomal Disorders : Presymptomatic patient inherit peroxisomal disorder associate long chain fatty acid ( VLCFA ) elevation , identify family history laboratory testing ( include neonatal screening ) , eligible protocol . White matter disease MRI alone exclusion patient asymptomatic . Other Inherited Diseases Metabolism : Wolman syndrome ( acid lipase deficiency ) NiemannPick B patient ( sphingomyelin deficiency ) NiemannPick C subtype 2 Donor Availability : Patients consider transplantation must sufficient graft base current criterion University Minnesota Blood Marrow Transplantation Program : Priority follow , although circumstance time essence , cord blood graft may choose unrelated graft , despite priority list . Multidisciplinary Evaluation : Patients eligible transplantation see evaluated member Inherited Metabolic Storage Disease Program ( IMSD ) team , team offer transplantation patient/family . Symptomatic patient peroxisomal lysosomal disorder exclude may consider treatment protocol . Major organ dysfunction . Evidence major organ impairment , include : Cardiac : leave ventricular ejection fraction &lt; 40 % Renal : serum creatinine &gt; 2.5 x normal age Hepatic : total bilirubin &gt; 3 x normal , Alanine transaminase ( ALT ) &gt; 3 x normal Pulmonary : requirement continuous oxygen supplementation Pregnancy Evidence human immunodeficiency virus ( HIV ) infection know HIV positive serology Patients &gt; 21 year age .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Inborn error metabolism</keyword>
	<keyword>Sphingolipidoses</keyword>
	<keyword>Recessive Leukodystrophies- GLD , Krabbe disease , MLD</keyword>
	<keyword>Peroxisomal Disorders</keyword>
	<keyword>Wolman syndrome</keyword>
	<keyword>Niemann-Pick B patient</keyword>
	<keyword>Niemann-Pick C subtype 2</keyword>
</DOC>